Company / Free Cash Flow per Share
Matinas BioPharma Holdings, Inc. Free Cash Flow per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.09
FY2023
5-year range
-$0.11 / -$0.07
FY2019-FY2023
Trend
-28.9%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-0.24 in FY2015 to $-0.07 in FY2022.
Based on SEC 10-K filings.
-0.09 in FY2023.
Declined from $-0.08 to $-0.09 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, free cash flow per share decreased 28.9% year-over-year.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -$0.09 | -28.9% |
| FY2022 | -$0.07 | +7.5% |
| FY2021 | -$0.08 | +27.3% |
| FY2020 | -$0.11 | -11.1% |
| FY2019 | -$0.10 | +27.8% |
| FY2018 | -$0.13 | +2.1% |
| FY2017 | -$0.14 | -26.8% |
| FY2016 | -$0.11 | +56.2% |
| FY2015 | -$0.24 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026